Programmable folding of fusion RNA in vivo and in vitro driven by pRNA 3WJ motif of phi29 DNA packaging motor

Nucleic Acids Research

Volumn 42, Issue 2, 2014, Pages

  Shu, Dan ^a   Khisamutdinov, Emil F ^a   Zhang, Le ^a   Guo, Peixuan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; MALACHITE GREEN; NUCLEOTIDE; RIBOZYME; RNA; SMALL INTERFERING RNA; STREPTAVIDIN; NANOPARTICLE; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DNA PACKAGING; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; RNA CONFORMATION; RNA FOLDING; RNA SEQUENCE; RNA TRANSCRIPTION; SPINACH; BACILLUS PHAGE; CHEMISTRY; FLUORESCENCE; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NUCLEOTIDE MOTIF; SEQUENCE ANALYSIS; TUMOR CELL LINE;

APTAMERS, NUCLEOTIDE; BACILLUS PHAGES; CELL LINE, TUMOR; FLUORESCENCE; GENE SILENCING; HUMANS; NANOPARTICLES; NUCLEOTIDE MOTIFS; RNA FOLDING; RNA, CATALYTIC; RNA, SMALL INTERFERING; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; STREPTAVIDIN; TRANSCRIPTION, GENETIC;

EID: 84893335635     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt885     Document Type: Article

References (61)

1. Guo, P., Zhang, C., Chen, C., Trottier, M. and Garver, K. (1998) Inter-RNA interaction of phage phi29 pRNA to form a hexameric complex for viral DNA transportation. Mol. Cell., 2, 149-155.
2. Guo, P. (2010) The emerging field of RNA nanotechnology. Nature Nanotechnology, 5, 833-842.
3. Markham, N.R. and Zuker, M. (2008) UNAFold: software for nucleic acid folding and hybridization. Methods Mol. Biol., 453, 3-31.
4. Zuker, M. (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res., 31, 3406-3415.
5. Chan, L., Zuker, M. and Jacobson, A.B. (1990) A computer method for finding common base paired helices in aligned sequences: application to the analysis of random sequences. Nucleic Acids Res., 19, 353-358.
6. Shu, D., Shu, Y., Haque, F., Abdelmawla, S. and Guo, P. (2011) Thermodynamically stable RNA three-way junctions for constructing multifuntional nanoparticles for delivery of therapeutics. Nature Nanotechnology, 6, 658-667.
7. Reif, R., Haque, F. and Guo, P. (2013) Fluorogenic RNA nanoparticles for monitoring RNA Folding and degradation in real time in living cells. Nucleic Acid Ther., 22, 428-437.
8. Haque, F., Shu, D., Shu, Y., Shlyakhtenko, L., Rychahou, P., Evers, M. and Guo, P. (2012) Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers. Nano Today, 7, 245-257.
9. Felden, B., Florentz, C., Giegé, R. and Westhof, E. (1996) A central pseudoknotted three-way junction imposes tRNA-like mimicry and the orientation of three 50 upstream pseudoknots in the 30 terminus of tobacco mosaic virus RNA. RNA, 2, 201-212.
10. Nasalean, L., Baudrey, S., Leontis, N.B. and Jaeger, L. (2006) Controlling RNA self-assembly to form filaments. Nucleic Acids Res., 34, 1381-1392.
11. Severcan, I., Geary, C., Verzemnieks, E., Chworos, A. and Jaeger, L. (2009) Square-shaped RNA particles from different RNA folds. Nano Lett., 9, 1270-1277.
12. Shu, Y., Haque, F., Shu, D., Li, W., Zhu, Z., Kotb, M., Lyubchenko, Y. and Guo, P. (2013) Fabrication of 14 Different RNA nanoparticles for specific tumor targeting without accumulation in normal organs. RNA, 19, 766-777.
13. Grabow, W.W., Zakrevsky, P., Afonin, K.A., Chworos, A., Shapiro, B.A. and Jaeger, L. (2011) Self-assembling RNA nanorings based on RNAI/II inverse kissing complexes. Nano Lett., 11, 878-887.
14. Ohno, H., Kobayashi, T., Kabata, R., Endo, K., Iwasa, T., Yoshimura, S.H., Takeyasu, K., Inoue, T. and Saito, H. (2011) Synthetic RNA-protein complex shaped like an equilateral triangle. Nat. Nanotechnol., 6, 116-120.
15. Schroeder, K.T., McPhee, S.A., Ouellet, J. and Lilley, D.M. (2010) A structural database for k-turn motifs in RNA. RNA., 16, 1463-1468.
16. Ishikawa, J., Fujita, Y., Maeda, Y., Furuta, H. and Ikawa, Y. (2010) GNRA/receptor interacting modules: Versatile modular units for natural and artificial RNA architectures. Methods, 54, 226-238.
17. Novikova, I.V., Hassan, B.H., Mirzoyan, M.G. and Leontis, N.B. (2010) Engineering cooperative tecto-RNA complexes having programmable stoichiometries. Nucleic Acids Res., 39, 2903-2917.
18. Shu, D., Moll, W.D., Deng, Z., Mao, C. and Guo, P. (2004) Bottom-up assembly of RNA arrays and superstructures as potential parts in nanotechnology. Nano Lett., 4, 1717-1723.
19. Khaled, A., Guo, S., Li, F. and Guo, P. (2005) Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology. Nano Letters, 5, 1797-1808.
20. Guo, P. (2005) RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy. J. Nanosci. Nanotechnol., 5, 1964-1982.
21. Guo, S., Huang, F. and Guo, P. (2006) Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells. Gene Ther., 13, 814-820.
22. Abdelmawla, S., Guo, S., Zhang, L., Pulukuri, S., Patankar, P., Conley, P., Trebley, J., Guo, P. and Li, Q.X. (2011) Pharmacological characterization of chemically synthesized monomeric pRNA nanoparticles for systemic delivery. Mol. Ther., 19, 1312-1322.
23. Ponchon, L. and Dardel, F. (2011) Large scale expression and purification of recombinant RNA in Escherichia coli. Methods, 54, 267-273.
24. Taft, R.J., Pang, K.C., Mercer, T.R., Dinger, M. and Mattick, J.S. (2010) Non-coding RNAs: regulators of disease. J. Pathol., 220, 126-139.
25. Duchaine, T.F. and Slack, F.J. (2009) RNA interference and micro-RNA-oriented therapy in cancer: rationales, promises, and challenges. Curr. Oncol., 16, 265-270.
26. Cayrol, B., Nogues, C., Dawid, A., Sagi, I., Silberzan, P. and Isambert, H. (2009) A nanostructure made of a bacterial noncoding RNA. J. Am. Chem. Soc., 131, 17270-17276.
27. Mattick, J.S. (2009) The genetic signatures of noncoding RNAs. PLoS. Genet., 5, e1000459.
28. Schroeder, R., Grossberger, R., Pichler, A. and Waldsich, C. (2002) RNA folding in vivo. Curr. Opin. Struct. Biol., 12, 296-300.
29. Donahue, C.P., Yadava, R.S., Nesbitt, S.M. and Fedoruk, M.N. (2000) The kinetic mechanism of the hairpin ribozyme in vivo: influence of RNA helix stability on intracellular cleavage kinetics. J. Mol. Biol., 295, 693-707.
30. Donahue, C.P. and Fedor, M.J. (1997) Kinetics of hairpin ribozyme cleavage in yeast. RNA, 3, 961-973.
31. Babendure, J.R., Adams, S.R. and Tsien, R.Y. (2003) Aptamers switch on fluorescence of triphenylmethane dyes. J. Am. Chem. Soc., 125, 14716-14717.
32. Afonin, K.A., Danilov, E.O., Novikova, I.V. and Leontis, N.B. (2008) TokenRNA: A new type of sequence-specific, label-free fluorescent biosensor for folded RNA molecules. Chembiochem, 9, 1902-1905.
33. Knapp, G. (1989) Enzymatic approaches to probing of RNA secondary and tertiary structure. Methods Enzymol., 180, 192-212.
34. Peattie, D.A. and Gilbert, W. (1980) Chemical probes for higher-order structure in RNA. Proc. Natl Acad. Sci. USA, 77, 4679-4682.
35. Trottier, M., Mat-Arip, Y., Zhang, C., Chen, C., Sheng, S., Shao, Z. and Guo, P. (2000) Probing the structure of monomers and dimers of the bacterial virus phi29 hexamer RNA complex by chemical modification. RNA, 6, 1257-1266.
36. Zhang, C., Trottier, M., Chen, C. and Guo, P. (2001) Chemical modification patterns of active and inactive as well as procapsidbound and unbound DNA-packaging RNAof bacterial virus Phi29. Virology, 281, 281-293.
37. Mat-Arip, Y., Garver, K., Chen, C., Sheng, S., Shao, Z. and Guo, P. (2001) Three-dimensional interaction of Phi29 pRNA dimer probed by chemical modification interference, cryo-AFM, and cross-linking. J. Biol. Chem., 276, 32575-32584.
38. Krol, A. and Carbon, P. (1989) A guide for probing native small nuclear RNA and ribonucleoprotein structures. Meth. Enzymol., 180, 213-227.
39. Ehresmann, C., Baudin, F., Mougel, M., Romby, P., Ebel, J.-P. and Ehresmann, B. (1987) Probing the structure of RNAs in solution. Nucleic Acids Res., 15, 9109-9128.
40. Moazed, U., Stern, S. and Noller, H.F. (1986) Rapid chemical probing of conformation in 16S ribosomal RNA and 30S ribosomal subunits using primer extension. J. Mol. Biol., 187, 399-416.
41. Lindell, M., Romby, P. and Wagner, E.G. (2002) Lead(II) as a probe for investigating RNA structure in vivo. RNA, 8, 534-541.
42. Wang, X.D. and Padgett, R.A. (1989) Hydroxyl radical " footprinting" of RNA: application to pre-mRNA splicing complexes. Proc. Natl Acad. Sci., 86, 7795-7799.
43. Zhang, H., Endrizzi, J.A., Shu, Y., Haque, F., Sauter, C., Shlyakhtenko, L.S., Lyubchenko, Y., Guo, P. and Chi, Y.I. (2013) Crystal structure of 3WJ core revealing divalent ion-promoted thermostability and assembly of the Phi29 hexameric motor pRNA. RNA, 19, 1226-1237.
44. Shu, D., Huang, L., Hoeprich, S. and Guo, P. (2003) Construction of phi29 DNA-packaging RNA (pRNA) monomers, dimers and trimers with variable sizes and shapes as potential parts for nano-devices. J. Nanosci. Nanotechnol., 3, 295-302.
45. Hoeprich, S., ZHou, Q., Guo, S., Qi, G., Wang, Y. and Guo, P. (2003) Bacterial virus phi29 pRNA as a hammerhead ribozyme escort to destroy hepatitis B virus. Gene Ther., 10, 1258-1267.
46. Feng, Y., Kong, Y.Y., Wang, Y. and Qi, G.R. (2001) Inhibition of hepatitis B virus by hammerhead ribozyme targeted to the poly(A) signal sequence in cultured cells. Biol Chem, 382, 655-660.
47. Ponchon, L. and Dardel, F. (2007) Recombinant RNA technology: the tRNA scaffold. Nat Methods, 4, 571-576.
48. Shu, Y., Shu, D., Haque, F. and Guo, P. (2013) Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells. Nat Protoc., 8, 1635-1659.
49. Ambrosini, G., Adida, C., Sirugo, G. and Altieri, D.C. (1998) Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J. Biol. Chem., 273, 11177-11182.
50. Ambrosini, G., Adida, C. and Altieri, D.C. (1997) A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med., 3, 917-921.
51. Baugh, C., Grate, D. and Wilson, C. (2000) 2.8 A crystal structure of the malachite green aptamer. J. Mol. Biol., 301, 117-128.
52. Paige, J.S., Wu, K.Y. and Jaffrey, S.R. (2011) RNA mimics of green fluorescent protein. Science, 333, 642-646.
53. Srisawat, C. and Engelke, D.R. (2001) Streptavidin aptamers: affinity tags for the study of RNAs and ribonucleoproteins. RNA, 7, 632-641.
54. Lu, Y. and Low, P.S. (2002) Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev., 54, 675-693.
55. Puglisi, J.D., Wyatt, J.R. and Tinoco, I. Jr (1988) A pseudoknotted RNA oligonucleotide. Nature, 331, 283-286.
56. Isambert, H. (2009) The jerky and knotty dynamics of RNA. Methods, 49, 189-196.
57. Mathews, D.H. and Turner, D.H. (2006) Prediction of RNA secondary structure by free energy minimization. Curr. Opin. Struct. Biol., 16, 270-278.
58. Bindewald, E., Afonin, K., Jaeger, L. and Shapiro, B.A. (2011) Multistrand RNA secondary structure prediction and nanostructure design including pseudoknots. ACS Nano., 5, 9542-9551.
59. Pleij, C.W.A., Rietveld, K. and Bosch, L. (1985) A new principle of RNA folding based on pseudonotting. Nucleic Acids Res., 13, 1717-1731.
60. Milligan, J.F., Groebe, D.R., Witherell, G.W. and Uhlenbeck, O.C. (1987) Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acid Res., 15, 8783-8798.
61. He, Y.K., Lu, C.D. and Qi, G.R. (1993) In vitro cleavage of HPV16 E6 and E7 RNA fragments by synthetic ribozymes and transcribed ribozymes from RNA-trimming plasmids. FEBS Lett., 322, 21-24.